Publication | Open Access
Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter study
18
Citations
18
References
2022
Year
IsoPSA has the potential to reduce unnecessary biopsies and improve the risk-benefit ratio for CaP early detection.
| Year | Citations | |
|---|---|---|
Page 1
Page 1